Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Glumin XR 500mg extended-release tablets

Ferron Par Pharmaceuticals

Ingredients in every extended-release tablet

Metformin HCL 500 mg

Each package contains

3 blisters of 10 extended-release tablets

Dosage form

extended-release tablet

Dosage formTablet; coated; extended-release

Flavour

None

W.H.O. classification

A10B
A10B

A.T.C. Level 1

Anatomical Main group

A - Alimentary tract and metabolism
A10B

A.T.C. Level 2

Therapeutic subgroup

A10 - Drugs Used in Diabetes
A10B

A.T.C. Level 3

Pharmacological subgroup

A10B - Blood Glucose Lowering Drugs; excl. Insulins

Available in

Indonesia
Myanmar
Cambodia

Warnings

Alcohol

NOT RECOMMENDEDThis item should not be used with alcohol.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

As mono– or combined therapy
with sulphonylurea in patients with Non-insulin-dependent diabetes mellitus (type-2 diabetes) especially if overweight and whose blood glucose level cannot be controlled by diet alone.
As an adjuvant therapy
in insulin-dependent diabetic patients with hardly controlled symptoms.

Dosage

17 YEARS OLD AND ABOVE
GLUMIN XR® should generally be given once daily with the evening meal and should be started at a low dose, with gradual dose escalation. Subsequent dosage should be adjusted according to the patient’s therapeutic response, using the lowest possible effective dosage. GLUMIN XR® must be swallowed whole and never crushed or chewed.

In adults, the usual starting dose of GLUMIN XR® is 500 mg once daily with the evening meal. Maximum recommended daily dose in adults is 2,000 mg.

Dosage increases should be made in increments of 500 mg weekly, up to a maximum of 2,000 mg once daily with the evening meal. If glycemic control is not achieved on GLUMIN XR® 2,000 mg once daily, a trial of GLUMIN XR® 1,000 mg twice daily should be considered.

0 TO 17 YEARS OLD
Safety and effectiveness of GLUMIN XR® in pediatric patients have not been established. GLUMIN XR® is not recommended in pediatric patients below the age of 17 years.

ELDERLY PATIENTS
Caution is advised in elderly patients because of the reduced renal function. Hence renal function should be monitored regularly.